NCM·Healthcare·$59M·#265 / 520 in Healthcare
DXR Daxor Corporation
43SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY0
STABILITY33
VALUATION0
GOVERNANCE85
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+383.5%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
0 months
0
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
1.6%
99
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2209.7x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
N/A
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
49.0%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+7.7%
54
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE DXR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when DXR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.